Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

1.27
Delayed Data
As of 11:17am ET
 +0.03 / +2.42%
Today’s Change
1.19
Today|||52-Week Range
1.75
-8.63%
Year-to-Date

Today’s Trading

Previous close1.24
Today’s open1.25
Day’s range1.24 - 1.30
Volume394,465
Average volume (3 months)1,174,013
Market cap$247.9M
Dividend yield--
Data as of 11:17am ET, 07/28/2015

Growth & Valuation

Earnings growth (last year)-36.36%
Earnings growth (this year)-3.33%
Earnings growth (next 5 years)--
Revenue growth (last year)+19.55%
P/E ratioNM
Price/Sales8.93
Price/Book4.09

Competitors

 Today’s
change
Today’s
% change
TBRATobira Therapeutics ...+0.31+2.25%
CORICorium International...+0.18+1.33%
TRVNTrevena Inc-0.05-0.81%
AGRXAgile Therapeutics I...-0.01-0.10%
Data as of 11:29am ET, 07/28/2015

Financials

Next reporting dateSeptember 7, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$26.8M
Annual profit (last year)-$50.4M
Net profit margin-188.04%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
CFO &
Principal Accounting Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers